# Dennis Schafer

> Dennis Schafer is a startup investor at BioGenerator. See 0 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [BioGenerator](https://shizune.co/investors/profile/biogenerator)
- Last updated: Aug 2026

Dennis Schafer is an accomplished entrepreneur with more than 25 years' experience in organizing and managing new life science ventures, primarily in the Southeastern and Midwestern regions. In addition to his role as a Senior Entrepreneur in Residence at Biogenerator, he currently serves as President and CEO of Altheus Therapeutics, aMidwestern-based company pursuing mid-stage clinical development of a novel combination therapy for ulcerative colitis. Dennis has played leadership roles in twelve start-ups, serving as CEO in several of them, accessing technologies from multiple universities as well as corporate sources; raising start-up capital from more than a dozen institutional venture funds; and forming corporate partnerships with both major and mid-major pharmaceutical companies. Companies in his portfolio include BioCryst Pharmaceuticals, Zynaxis (acquired Secretech), Avant Immunotherapeutics (acquired Megan Health), Coley Pharmaceuticals, Aderis Pharmaceuticals, Somatacor, Curry Pharmaceuticals, FASgen, and Altheus Therapeutics. Collectively, these companies have launched a new drug for Parkinson’s Disease, advanced several other human products into clinical testing, and launched two animal vaccines. Four of the companies have become publicly traded, and four have been acquired by larger biotech or pharma companies.Dennis received his BA with distinction from the University of Nebraska, and earned an MA in English and an MBA from the University of Virginia, where he also served for two years as a member of the research faculty in business strategy at the Darden Graduate School of Business.

## Contacts

5 contacts available for Dennis Schafer: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/dennis-schafer?utm_source=investor_profile

## About BioGenerator

VC Fund · St Louis, United States

The BioGenerator, the non-profit venture development organization of BioSTL, facilitates the formation of successful, sustainable bioscience companies in the St. Louis region. It provides start-up bioscience companies with pre-seed and seed investment funds, shared lab space with specialized equipment, and in-depth management support.

5 contacts available at BioGenerator.

| Name | Title | Profile |
| --- | --- | --- |
| Charlie Bolten | Vice President | — |
| Dan Broderick | Vice President | https://shizune.co/investors/profile/dan-broderick |
| David Christenson | Entrepreneur In Residence | — |
| Dennis Schafer | Senior Entrepreneur in Residence | — |
| Nandini Kishore | Entrepreneur in Residence | — |

## FAQ

### How do I contact Dennis Schafer?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co